Rankings
▼
Calendar
SAVA Q3 2021 Earnings — Cassava Sciences, Inc. Revenue & Financial Results | Market Cap Arena
SAVA
Cassava Sciences, Inc.
$115M
Q3 2021 Earnings
Healthcare
Biotechnology
Income Statement
Revenue
$0
Gross Profit
-$8M
Operating Income
-$10M
Net Income
-$10M
EPS (Diluted)
$-0.24
QoQ Revenue Growth
NaN%
Cash Flow
Operating Cash Flow
-$15M
Free Cash Flow
-$37M
Stock-Based Comp.
$572,000
Balance Sheet
Total Assets
$274M
Total Liabilities
$7M
Stockholders' Equity
$268M
Cash & Equivalents
$242M
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$0
$0
—
Gross Profit
-$8M
-$399,000
-1915.3%
Operating Income
-$10M
-$1M
-578.7%
Net Income
-$10M
-$1M
-568.7%
← FY 2021
All Quarters
Q4 2021 →